{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T20:06:28Z","timestamp":1794254788621,"version":"4.9.0"},"reference-count":12,"publisher":"SLACK, Inc.","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Pediatr Ophthalmol Strabismus"],"published-print":{"date-parts":[[2006,1]]},"abstract":"<jats:p>Abstract<\/jats:p>\n          <jats:p>Objectives: To describe the characteristics of fundus fluorescein angiography in retinopathy of prematurity (ROP) and to explore the possible benefits of fundus fluorescein angiography over conventional indirect ophthalmoscopy in the screening for and management of ROP.<\/jats:p>\n          <jats:p>Patiente and Methods: Beginning in January 2003, 23 consecutive patients were recruited for a nonrandomized, investigational trial. Fifty-one sessions of fundus fluorescein angiography were performed as part of ROP screening.<\/jats:p>\n          <jats:p>Resulte: Fundus fluorescein angiography caused no adverse effect. Clear angiograms were easily obtained. There was delayed arm-to-eye fluorescein transit. Leakage of fluorescein was observed in all stage 2 and stage 3 ROP The leakage resolved soon after treatment. Arteriovenous tufts were found far posterior to the ROP ridge and were a feature of severe ROP<\/jats:p>\n          <jats:p>Conclusions: Some vascular pathology observed on angiograms cannot be seen on indirect ophthalmoscopy. There was delayed arm-to-eye transit and fluorescein transit within the eyes. Fundus fluorescein angiography allows more objective assessment of disease stage and zone. Regression of ROP is clearly observed on fundus fluorescein angiography.<\/jats:p>\n          <jats:p>J Pediatr Ophthalmol Strabismus 2006;43:85-90.<\/jats:p>","DOI":"10.3928\/0191-3913-20060301-07","type":"journal-article","created":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T18:45:08Z","timestamp":1579632308000},"page":"85-90","source":"Crossref","is-referenced-by-count":50,"title":["Fundus Fluorescein Angiography in the Screening for and Management of Retinopathy of Prematurity"],"prefix":"10.3928","volume":"43","author":[{"given":"Eugene Y J","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadette","family":"Lanigan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"O'Keefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2308","reference":[{"key":"e_1_3_1_2_1","doi-asserted-by":"crossref","unstructured":"1. The Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Arch Ophthalmol 1984;102:1130-1134.","DOI":"10.1001\/archopht.1984.01040030908011"},{"key":"e_1_3_1_3_1","doi-asserted-by":"crossref","unstructured":"2. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results. Arch Ophthalmol 1988;106:471-479.","DOI":"10.1001\/archopht.1988.01060130517027"},{"key":"e_1_3_1_4_1","doi-asserted-by":"crossref","unstructured":"3. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: 356-year outcome. Structure and function. Arch Ophthalmol 1993;111:339-344.","DOI":"10.1001\/archopht.1993.01090030057039"},{"key":"e_1_3_1_5_1","doi-asserted-by":"crossref","unstructured":"4. Ng EY Connolly BP McNamara JA et aL A comparison of laser photocoagulation with cryotherapy for threshold retinopathy of prematurity at 10 years: Part 1. Visual function and structural outcome. Ophthalmology 2002; 1 09: 928-935.","DOI":"10.1016\/S0161-6420(01)01017-X"},{"key":"e_1_3_1_6_1","doi-asserted-by":"crossref","unstructured":"5. O'Keef\u00e9 M O'Reilly J Lanigan B. Longer-term visual outcome of eyes with retinopathy of prematurity treated with cryotherapy or diode laser. BrJ Ophthalmol 1998;82:1246-1248.","DOI":"10.1136\/bjo.82.11.1246"},{"key":"e_1_3_1_7_1","doi-asserted-by":"crossref","unstructured":"6. Pearce IA Pennie FC Gannon LM et aL Three-year visual outcome for treated stage 3 retinopathy of prematurity: cryotherapy versus laser. BrJ Ophthalmol 1998;82:1254-1259.","DOI":"10.1136\/bjo.82.11.1254"},{"key":"e_1_3_1_8_1","doi-asserted-by":"crossref","unstructured":"7. Shalev B Farr AK Repka MX. Randomized comparison of diode laser photocoagulation versus cryotherapy for threshold retinopathy of prematurity: seven-year outcome. AmJ Ophthalmol 2001;132:76-80.","DOI":"10.1016\/S0002-9394(01)00956-4"},{"key":"e_1_3_1_9_1","doi-asserted-by":"crossref","unstructured":"8. Flynn JT Cassady J Essner D et aL Fluorescein angiography in retrolental fibroplasia: experience fem 1969-1977. Ophthalmology 1979;86:1700-1723.","DOI":"10.1016\/S0161-6420(79)35329-5"},{"key":"e_1_3_1_10_1","doi-asserted-by":"crossref","unstructured":"9. Schwartz SD Harrison SA Ferrone PJ et al. Telemedicai evaluation and management of retinopathy of prematurity using a fiberoptic digital fundus camera. Ophthalmology 2000; 107:25-28.","DOI":"10.1016\/S0161-6420(99)00003-2"},{"key":"e_1_3_1_11_1","unstructured":"10. Roth DB Morales D Feuer WJ et aL Screening for retinopathy of prematurity employing the RetCam 120: sensitivity and specificity. Arch Ophthalmol200l;ll9:268-272."},{"key":"e_1_3_1_12_1","doi-asserted-by":"crossref","unstructured":"11. Yen KG Hess D Burke B et aL Telephotoscreening to detect retinopathy of prematurity: preliminary study of the optimum time to employ digital fundus camera imaging to detect ROR J AAPOS 2002;6:64-70.","DOI":"10.1067\/mpa.2002.121616"},{"key":"e_1_3_1_13_1","doi-asserted-by":"crossref","unstructured":"12. Ells AL Holmes JM Astle WF et aL Telemedicine approach to screening for severe retinopathy of prematurity: a pilot study. Ophthaknology2003; 110:21 13-2117.","DOI":"10.1016\/S0161-6420(03)00831-5"}],"container-title":["Journal of Pediatric Ophthalmology &amp; Strabismus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.healio.com\/ophthalmology\/journals\/jpos\/2006-3-43-2\/%7B2c02744e-fcba-4a77-b0db-a12522c1cf2b%7D\/fundus-fluorescein-angiography-in-the-screening-for-and-management-of-retinopathy-of-prematurity","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,2]],"date-time":"2023-05-02T22:04:23Z","timestamp":1683065063000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.healio.com\/doi\/10.3928\/0191-3913-20060301-07"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["10.3928\/0191-3913-20060301-07"],"URL":"https:\/\/doi.org\/10.3928\/0191-3913-20060301-07","relation":{},"ISSN":["0191-3913","1938-2405"],"issn-type":[{"value":"0191-3913","type":"print"},{"value":"1938-2405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1]]}}}